Shanghai Hile Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000022T4
CNY
7.06
0.26 (3.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai Hile Bio-Technology Co., Ltd.
Why is Shanghai Hile Bio-Technology Co., Ltd. ?
1
  • PRE-TAX PROFIT(Q) At CNY 20.56 MM has Fallen at -60.92%
  • NET PROFIT(Q) At CNY 10.53 MM has Fallen at -76.86%
  • NET SALES(Q) At CNY 61.34 MM has Fallen at -8.14%
2
Below par performance in long term as well as near term
  • Along with generating -12.52% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Hile Bio-Technology Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shanghai Hile Bio-Technology Co., Ltd.
-12.52%
0.08
28.74%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.08%
EBIT Growth (5y)
33.09%
EBIT to Interest (avg)
1.32
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.18
Tax Ratio
13.73%
Dividend Payout Ratio
29.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.79%
ROE (avg)
6.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.75
EV to EBIT
55.69
EV to EBITDA
38.91
EV to Capital Employed
3.52
EV to Sales
14.36
PEG Ratio
0.05
Dividend Yield
1.16%
ROCE (Latest)
6.32%
ROE (Latest)
13.47%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
NET SALES(HY)

At CNY 156.31 MM has Grown at 36.03%

NET PROFIT(HY)

Higher at CNY 172.39 MM

RAW MATERIAL COST(Y)

Fallen by -87.37% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -29.11 %

DEBTORS TURNOVER RATIO(HY)

Highest at 2.18%

-7What is not working for the Company
PRE-TAX PROFIT(Q)

At CNY 20.56 MM has Fallen at -60.92%

NET PROFIT(Q)

At CNY 10.53 MM has Fallen at -76.86%

NET SALES(Q)

At CNY 61.34 MM has Fallen at -8.14%

Here's what is working for Shanghai Hile Bio-Technology Co., Ltd.
Debt-Equity Ratio
Lowest at -29.11 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 2.18%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -87.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Hile Bio-Technology Co., Ltd.
Pre-Tax Profit
At CNY 20.56 MM has Fallen at -60.92%
over average net sales of the previous four periods of CNY 52.61 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 10.53 MM has Fallen at -76.86%
over average net sales of the previous four periods of CNY 45.53 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
At CNY 61.34 MM has Fallen at -8.14%
over average net sales of the previous four periods of CNY 66.78 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)